SAITAMA – The parents of a teenage girl who died last year after allegedly being given an excessive amount of an anticancer drug, sued on Friday a Saitama Prefecture hospital and six of its officials, demanding 230 million yen in damages for their daughter’s death.
According to the petition, an attending doctor at the Saitama Medical Center of Saitama Medical School in Kawagoe gave an excessive dose of medicine to 16-year-old Yuri Furudate, of Konosu in the prefecture, resulting in her death of multiple organ failure on Oct. 7.
Her parents claim that the doctor misread the prescription.
Furudate, a second-year student at a private high school, was being treated for a tumor in her chin.
Police are investigating the case as one of malpractice resulting in death.
Investigators believe the 31-year-old doctor was unable to read the name of the ailment, which was written in English on Furudate’s chart. The doctor, who was not identified, also misdiagnosed his patient, telling Furudate’s parents she had a different disease.
According to the petition, the doctor failed to begin treatment that could have saved Furudate’s life after discovering that he had given her an excessive amount of an anticancer drug.
He then lied about his error to the girl’s parents and wrote out a false death certificate that said she died because the cancer had spread throughout her body.
The petition says the hospital, which admitted malpractice and apologized to the parents, has reprimanded five senior officials and dismissed the attending doctor.
But the doctor later told the parents the hospital had tried to cover up the malpractice, according to the suit.
“We want to know the truth behind the death of our daughter,” the parents told reporters Friday. “We filed the suit to make it clear who is responsible for her death.”
The hospital offered an apology to the parents Friday after hearing the suit was filed, but officials there declined further comment, saying they are under police investigation.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.